EUCTR2006-000708-18-FIActive, not recruitingNot Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT
Institut de Recherches Internationales Servier0 sites6,500 target enrollmentStarted: October 3, 2006Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 6,500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- male or female patients >= 18 years
- •- Chronic Heart Failure
- •- left ventricular systolic dysfunction
- •- sinus rythm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- unstable cardiovascular condition
- •- recent myocardial infarction or coronary revascularisation
- •- congenital heart diseases
- •- severe valvular disease
- •- active myocarditis
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTEUCTR2006-000708-18-NLInstitut de Recherches Internationales Servier5,500
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTEUCTR2006-000708-18-LVInstitut de Recherches Internationales Servier5,500
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTcardiac failure chronicMedDRA version: 9.0Level: PTClassification code 10007558EUCTR2006-000708-18-ATInstitut de Recherches Internationales Servier6,500
Active, not recruiting
Phase 1
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIFCoronary artery diseaseMedDRA version: 7.0 Level: PT Classification code 10011078EUCTR2004-001959-11-GBInstitut de Recherches Internationales9,650
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIFEUCTR2004-001959-11-EEInstitut de Recherches Internationales Servier9,650